Similar articles

• [Myocardial myofibrillary ATPase in cardiac failure].

  Swynghedauw B, Meignan M, Piguet V, Hatt PY. Swynghedauw B, et al. Arch Mal Coeur Vaiss. 1971 Nov;64(11):1547-56. Arch Mal Coeur Vaiss. 1971. PMID: 4260725 French. No abstract available.
• [Cathecholamine in heart failure (author's transl)].

  Yazaki Y, Ikeda M. Yazaki Y, et al. Kokyu To Junkan. 1975 May;23(5):397-404. Kokyu To Junkan. 1975. PMID: 169560 Review. Japanese. No abstract available.
• [Cardiac adaptation and compensation mechanism and their disorders in contractile insufficiency of the chronically overloaded heart].

  Urbaszek W. Urbaszek W. Z Gesamte Inn Med. 1971 Mar 15;26(6):189-98. Z Gesamte Inn Med. 1971. PMID: 4254533 Review. German. No abstract available.
• Myocardial metabolic changes in cardiac hypertrophy and heart failure.

  Fizelova A, Fizel A. Fizelova A, et al. Recent Adv Stud Cardiac Struct Metab. 1972;1:200-12. Recent Adv Stud Cardiac Struct Metab. 1972. PMID: 4283436 No abstract available.
• Cardiac hypertrophy and heart failure: dynamics of changes in high-energy phosphate compounds, glycogen and lactic acid.

  Fizel A, Fizelova A. Fizel A, et al. J Mol Cell Cardiol. 1971 Aug;2(3):187-92. doi: 10.1016/0022-2828(71)90052-6. J Mol Cell Cardiol. 1971. PMID: 4256075 No abstract available.